Your browser doesn't support javascript.
loading
Single cell T cell landscape and T cell receptor repertoire profiling of AML in context of PD-1 blockade therapy.
Abbas, Hussein A; Hao, Dapeng; Tomczak, Katarzyna; Barrodia, Praveen; Im, Jin Seon; Reville, Patrick K; Alaniz, Zoe; Wang, Wei; Wang, Ruiping; Wang, Feng; Al-Atrash, Gheath; Takahashi, Koichi; Ning, Jing; Ding, Maomao; Beird, Hannah C; Mathews, Jairo T; Little, Latasha; Zhang, Jianhua; Basu, Sreyashi; Konopleva, Marina; Marques-Piubelli, Mario L; Solis, Luisa M; Parra, Edwin Roger; Lu, Wei; Tamegnon, Auriole; Garcia-Manero, Guillermo; Green, Michael R; Sharma, Padmanee; Allison, James P; Kornblau, Steven M; Rai, Kunal; Wang, Linghua; Daver, Naval; Futreal, Andrew.
Afiliação
  • Abbas HA; Division of Cancer Medicine, Medical Oncology Fellowship, University of Texas M D Anderson Cancer Center, Houston, TX, USA.
  • Hao D; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Tomczak K; Division of Cancer Medicine, Medical Oncology Fellowship, University of Texas M D Anderson Cancer Center, Houston, TX, USA.
  • Barrodia P; Department of Genomic Medicine, University of Texas M D Anderson Cancer Center, Houston, TX, USA.
  • Im JS; Department of Genomic Medicine, University of Texas M D Anderson Cancer Center, Houston, TX, USA.
  • Reville PK; Department of Genomic Medicine, University of Texas M D Anderson Cancer Center, Houston, TX, USA.
  • Alaniz Z; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Wang W; Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Wang R; Division of Cancer Medicine, Medical Oncology Fellowship, University of Texas M D Anderson Cancer Center, Houston, TX, USA.
  • Wang F; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Al-Atrash G; Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Takahashi K; Department of Genomic Medicine, University of Texas M D Anderson Cancer Center, Houston, TX, USA.
  • Ning J; Department of Genomic Medicine, University of Texas M D Anderson Cancer Center, Houston, TX, USA.
  • Ding M; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Beird HC; Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Mathews JT; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Little L; Department of Genomic Medicine, University of Texas M D Anderson Cancer Center, Houston, TX, USA.
  • Zhang J; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Basu S; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Konopleva M; Department of Statistics, Rice University, Houston, TX, USA.
  • Marques-Piubelli ML; Department of Genomic Medicine, University of Texas M D Anderson Cancer Center, Houston, TX, USA.
  • Solis LM; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Parra ER; Department of Genomic Medicine, University of Texas M D Anderson Cancer Center, Houston, TX, USA.
  • Lu W; Department of Genomic Medicine, University of Texas M D Anderson Cancer Center, Houston, TX, USA.
  • Tamegnon A; Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Garcia-Manero G; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Green MR; Department Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Sharma P; Department Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Allison JP; Department Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Kornblau SM; Department Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Rai K; Department Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Wang L; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Daver N; Department of Genomic Medicine, University of Texas M D Anderson Cancer Center, Houston, TX, USA.
  • Futreal A; Department of Lymphoma and Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Nat Commun ; 12(1): 6071, 2021 10 18.
Article em En | MEDLINE | ID: mdl-34663807
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Antígenos de Linfócitos T / Linfócitos T / Leucemia Mieloide Aguda / Receptor de Morte Celular Programada 1 / Inibidores de Checkpoint Imunológico Limite: Aged / Aged80 / Humans / Middle aged Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Antígenos de Linfócitos T / Linfócitos T / Leucemia Mieloide Aguda / Receptor de Morte Celular Programada 1 / Inibidores de Checkpoint Imunológico Limite: Aged / Aged80 / Humans / Middle aged Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos